US$ 22.32
can you take tirzepatide and retatrutide together vs Semaglutide Tirzepatide: GLP-3 Facts explained Tirzepatide vs. Retatrutide | AlphaMan
Description
What is causing diabetes costs to stabilize for employers

Tirzepatide comes in a pen device that does not allow for custom dosing in the same way

By indication, type-2 diabetes remains the largest segment (57.6% of 2024 GLP-1 revenue, ~$31.1B) ( [22] ), followed by cardiovascular risk reduction (~19.6%, $16.0B) and obesity (~12.8%, $6.9B)

The final limitation is the low number of band adjustments performed during the first 6 months which is likely to explain the much lower than expected weight loss at 6 months and consequently the attenuated reduction in HbA1c

Storing the vial upright is the standard and recommended practice
